A mid-stage clinical trial of CagriSema showed that when combining the two drugs, patients’ body weight was reduced ... an ...
Rising numbers of people are needing hospital treatment for side effects from weight loss injections and it may be affecting ...
U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and ...
Sahpra warns of falsified diabetes treatments Ozempic and Mounjaro sold online for weight loss, posing health risks.
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy, Ozempic, and Rybelsus and ...
These drugs are used for diabetes and weight management ... studies have shown that they can also lead to significant weight ...
A study reveals racial and ethnic disparities in access to Novo Nordisk's diabetes and weight loss drugs among U.S. military veterans. Black, Asian, and Native American patients are less likely to ...
At dinner with my closest friend, conversation turns to weight-loss jabs, and quickly it becomes clear how strongly she ...
The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...